US Broker Ratings

Dynavax Technologies Corporation (DVAX) Investor Outlook: Exploring a 30.74% Potential Upside

Dynavax Technologies Corporation (NASDAQ: DVAX) is attracting attention in the healthcare sector with its promising trajectory in the vaccine development space. As a commercial-stage biopharmaceutical company, Dynavax is making waves..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: 9.08% Potential Upside Amid Promising Biotech Innovations

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), a key player in the biopharmaceutical sector, continues to capture the attention of investors with its promising advancements in autoimmune disease therapies. With a market..

Kiniksa Pharmaceuticals, Ltd. (KNSA) Stock Analysis: Uncovering a 33.75% Potential Upside in the Healthcare Sector

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) is making waves in the healthcare sector, particularly in drug manufacturing with a specialty in novel therapies targeting cardiovascular diseases. As a biopharmaceutical entity headquartered..

Indivior PLC (INDV) Stock Analysis: Exploring a 24% Upside Potential in the Healthcare Sector

Indivior PLC (INDV), a prominent player in the healthcare sector, is making waves on the financial markets with a compelling narrative that offers a potential upside of 24.01%. Specializing in..

Artivion, Inc. (AORT) Stock Analysis: 20% Upside Potential and a Strong Buy Consensus Signal Opportunity for Investors

Artivion, Inc. (NYSE: AORT), a key player in the healthcare sector specializing in medical devices, presents a compelling investment case with promising upside potential. With a market capitalization of $2.03..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Uncovering a 21.58% Upside Potential

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH), a prominent player in the healthcare sector, particularly within the medical care facilities industry, offers an intriguing opportunity for investors. With its current market..

ANI Pharmaceuticals, Inc. (ANIP) Investor Outlook: Exploring a 29.52% Potential Upside in the Healthcare Sector

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) stands out in the healthcare sector as a promising investment opportunity. With its focus on developing and marketing both branded and generic pharmaceutical products, ANI..

Mesoblast Limited (MESO) Stock Analysis: Exploring an 87% Potential Upside in Biotech Investments

In the dynamic world of biotechnology, Mesoblast Limited (NASDAQ: MESO) stands out as a key player with a remarkable potential upside of 87.47%. This Australian healthcare company is pioneering regenerative..

Travere Therapeutics, Inc. (TVTX) Investor Outlook: Strong Buy Ratings Signal 23.8% Upside Potential

Travere Therapeutics, Inc. (NASDAQ: TVTX), a biopharmaceutical company specializing in therapies for rare kidney and metabolic diseases, is capturing investor attention with its impressive revenue growth and robust analyst support...

Vera Therapeutics, Inc. (VERA) Stock Analysis: A 62% Upside Potential Amidst Strong Buy Ratings

Vera Therapeutics, Inc. (NASDAQ: VERA), a clinical-stage biotechnology firm, is piquing investor interest with its promising therapeutic pipeline and significant upside potential. Despite a challenging landscape, the company’s focus on..

Neogen Corporation (NEOG) Stock Analysis: Exploring 24.51% Potential Upside Amidst Strategic Growth in Diagnostics & Research

Neogen Corporation (NASDAQ: NEOG), a prominent player in the healthcare sector, operates within the diagnostics and research industry, focusing on food and animal safety. With a market capitalization of $2.04..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: Unveiling a 32.83% Potential Upside Amidst Promising Biotech Innovations

Investors with a keen eye on the healthcare sector should take note of Apogee Therapeutics, Inc. (NASDAQ: APGE), a promising player in the biotechnology industry. With a market capitalization of..

Acadia Healthcare (ACHC): Exploring a 57% Potential Upside in the Behavioral Healthcare Sector

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) stands as a significant player in the medical care facilities sector, focusing on behavioral healthcare services across the United States and Puerto Rico. With..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: A Look at Growth Potential Amidst Market Challenges

Pediatrix Medical Group, Inc. (NYSE: MD), a prominent player in the healthcare sector, is navigating the intricate landscape of medical care facilities in the United States. With a market capitalization..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: 19.5% Revenue Growth and Potential Upside Attract Investors

Amicus Therapeutics, Inc. (NASDAQ: FOLD), a biotechnology firm headquartered in Princeton, New Jersey, is making waves in the healthcare sector with its focus on rare diseases. Despite a flat price..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: A 126% Potential Upside in the Biotech Sector

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical firm based in Bedford, Massachusetts, is capturing investor attention with a compelling blend of innovative therapies and promising market potential. Specializing in the..

Structure Therapeutics Inc. (GPCR) Stock Report: Exploring a 46.75% Potential Upside in Biotech Innovation

Structure Therapeutics Inc. (NASDAQ: GPCR) stands at the forefront of the biotechnology landscape with a promising pipeline of innovative therapeutics aimed at addressing chronic diseases. With a robust market capitalization..

Ligand Pharmaceuticals (LGND) Stock Analysis: Riding on a Wave of Revenue Growth and Analyst Optimism

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) is making waves in the healthcare sector, particularly in the biotechnology industry. Based in Jupiter, Florida, Ligand has carved a niche by developing and licensing..

Novavax, Inc. (NVAX) Stock Analysis: Exploring a 64.87% Potential Upside Amid Volatile Biotech Landscape

Novavax, Inc. (NVAX), a prominent player in the biotechnology sector, has been making headlines with its innovative approach to vaccine development. Based in Gaithersburg, Maryland, the company is primarily known..

NovoCure Limited (NVCR) Stock Analysis: A Deep Dive into a 72.78% Potential Upside

NovoCure Limited (NASDAQ: NVCR) is a prominent player in the healthcare sector, specializing in medical devices aimed at treating solid tumor cancers. Headquartered in Baar, Switzerland, NovoCure has carved a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds